chr17-35258786-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144975.4(SLFN5):c.96C>A(p.Asp32Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000527 in 1,614,046 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144975.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLFN5 | NM_144975.4 | c.96C>A | p.Asp32Glu | missense_variant | 2/5 | ENST00000299977.9 | NP_659412.3 | |
SLFN5 | NM_001330183.2 | c.96C>A | p.Asp32Glu | missense_variant | 2/4 | NP_001317112.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLFN5 | ENST00000299977.9 | c.96C>A | p.Asp32Glu | missense_variant | 2/5 | 1 | NM_144975.4 | ENSP00000299977.3 | ||
SLFN5 | ENST00000592325.1 | c.96C>A | p.Asp32Glu | missense_variant | 2/2 | 1 | ENSP00000466984.1 | |||
SLFN5 | ENST00000542451.1 | c.96C>A | p.Asp32Glu | missense_variant | 2/4 | 2 | ENSP00000440537.1 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152156Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251462Hom.: 0 AF XY: 0.0000441 AC XY: 6AN XY: 135910
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1461890Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 727246
GnomAD4 genome AF: 0.000250 AC: 38AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2024 | The c.96C>A (p.D32E) alteration is located in exon 2 (coding exon 1) of the SLFN5 gene. This alteration results from a C to A substitution at nucleotide position 96, causing the aspartic acid (D) at amino acid position 32 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at